baber/WOPTO huggingface dataset:
Patent NZ-566153-A (NZ)
Title: Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection
Inventor: ZHANG QINGMIN
IPC: A61K9/06
Filed: 2006-07-21
Abstract: Disclosed is the use of a hydroxybenzoic acid ester and its analogues as set forth in Formula (I), and the pharmaceutically acceptable salts or solvates thereof: wherein R is an alkyl group; R1, R2, R3, R4 and R5 are independently OH or H; and at least one of which is OH; but salicylic acid ester is excluded; in the manufacture of a medicament or the prevention or treatment of a HPV virus infection in a human or animal, wherein the hydroxybenzoic acid ester and its analogues are used as a sole medicament.
Patent NZ-566803-A (NZ)
Title: Adjustable fender mount for a mud guard of a vehicle
Inventor: EKLUND WESLEY K
Filed: 2008-03-19
Abstract: A fender assembly (20) with an adjustably mounted fender for covering the wheels (14) of a heavy-duty vehicle is disclosed. The assembly includes a fender (22) having a panel with inner and outer side walls, and a clamping wall on the underside of the panel. The assembly further includes a mounting arm (26) to be attached to a vehicle frame at one end and adapted at the other end to extend transversely at least partially across the underside of the fender to support the fender. A pair of clamping members is mounted on the mounting arm to clamp an inner side edge of the fender and the clamping wall between them. The clamping members are selectively adjustable along the longitudinal length of the mounting arm.
Patent NZ-583491-A (NZ)
Title: Sea water treatment method and sea water treatment system
Inventor: NAGAO SHOZO
IPC: C02F1/66
Filed: 2005-01-27
Abstract: A sea water treatment method is disclosed. The seawater treatment method comprises providing aeration to a sulfur-absorbing solution produced by sea water desulfurization under conditions of a nozzle flow rate and a total aeration flow rate that fulfills the following equations (I), (II), and (III): (I) y ? 0 .526 + 0.0114x (II) 5 ? x ? 35 (III) y ? 1.32 In the equations (I), (II), and (III), y represents the total aeration flow rate (Nm3/t-sea water) and x represents the nozzle flow rate (Nm3/h/m).
Patent NZ-585658-A (NZ)
Title: Steaming interactive video of a twitch game or application which can be recorded and played back by a user
Inventor: PERLMAN STEPHEN G
IPC: G06F17/00
Filed: 2008-12-04
Abstract: Disclosed is a method of providing streaming interactive video. The method includes running a twitch video game or application on one or more servers of a hosting service centre, the twitch video game or application being played by at least one user remote to the hosting service centre over a packet-based network via low-latency compressed streaming interactive video displayed on at least one client device. The method also includes recording, by the hosting service centre, video output associated with the running of the twitch video game or application, the recording occurring as the twitch video game or application is being played. A user interface is provided that allows the at least one user to selectively replay any portion of the recorded video output.
Patent NZ-587738-A (NZ)
Title: Mounting instruments on a nacelle such that they can be drawn into nacelle to be serviced
Inventor: OEMANN LIND SOEREN
IPC: F03D11/00
Filed: 2010-09-01
Abstract: Disclosed is an arrangement with a nacelle (N) and with at least one instrument (INS) of a wind turbine. The instrument measures an environmental parameter, and is position on top and projects above the nacelle. The instrument is connected to a rod which interacts with a channel (CH) to be moved between a first and second position. The instrument is positioned within the nacelle at the first position for installation or servicing, and outside the nacelle at the second position for instrument operation.
Patent NZ-588696-A (NZ)
Title: Herbicide composition comprising an oil extract from a plant of the order pinales and weed control method
Inventor: SEKINO KEISUKE
IPC: A01P13/00
Filed: 2009-03-24
Abstract: Disclosed is a composition when used as a herbicide, comprising an oily extract as an active ingredient. The oily extract is obtained by: a) cooling steam generated during a drying step of lumber from trees belonging to the order Pinales, or b) steam distillation of lumber from trees belonging to the order Pinales, or c) hot water extraction of lumber from trees belonging to the order Pinales. Examples of trees belonging to the order Pinales include those belonging to the to the genus Cryptomeria, Thuja, Thujopsis, Chamaecyparis, Cupressus or Juniperus (belonging to the family Cupressaceae); or to the genus Picea, Tsuga, Cedrus, Pseudotsuga, Larix, Pinus or Abies (belonging to the family Pinaceae). Also disclosed is a weed control method, comprising application of the herbicide composition to target weeds.
Patent NZ-588860-A (NZ)
Title: CD20 antibodies with increased Fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: C12P21/04
Filed: 2004-11-05
Abstract: Provided is a humanized Type II anti-CD20 antigen binding molecule comprising a heavy chain with a specified sequence, including a variant thereof, wherein said variant comprises one or more substitutions selected from 516A, A24V, A28T, S30T, M34I, N35S and Y91L, E1 Q, G9A, Li 1V, V12K, G16S, L20V, A24V, F27Y, T28A, S30T, N35S, V48M and Y91L, the residue numbering according to the Kabat system, wherein said antigen binding molecule induces higher levels of apoptosis when incubated with CD20-positive human cells relative to a control under identical conditions using the C2B8 chimeric IgG1 antibody with an identical sequence to rituximab. Further provided are polynucleotides coding for the antibodies.
Patent NZ-588899-A (NZ)
Title: Crack Preventing Cornice using semi-detached flap on reverse side of cornice
Inventor: THOMPSON BILL
IPC: E04F19/00
Filed: 2010-10-29
Abstract: A cornice comprising a first engagement surface adapted to be fixedly installed to a ceiling and a second engagement surface having a flexible semidetached flap portion thereon. The semi-detached flap portion includes inner and outer surfaces and distally located first and second ends. The outer surface of the semi-detached flap portion is adapted to be fixedly secured to a wall surface and the inner surface of the first end of the flap portion is securely joined to the second engagement surface. Furthermore, the inner surface of the second end of the flap portion is frangibly joined to the second engagement surface and the inner surface of the flap portion between the first and second ends is unattached to the second engagement surface. This is noted to address the issue of known cracking at cornice to wall joints due to ceiling sinking.
Patent NZ-591087-A (NZ)
Title: Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxc d3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
Inventor: RAUM TOBIAS
IPC: C07K16/30
Filed: 2009-10-01
Abstract: Discloses a bi-specific single chain antibody molecule comprising (i) a first binding domain capable of binding to an epitope of human and Callithrix jacchus, Saguinus oedipus or Saimiri sciureus CD38 (epsilon) chain, wherein the epitope is part of an amino acid sequence in the group consisting of SEQ NOs. 2, 4, 6, or 8, and comprises at least the amino acid motif Gln-Asp-Gly-Asn- Glu (ii) a second binding domain capable of binding to an antigen selected from the group consisting of Prostate Stem Cell Antigen (PSCA), B-Lymphocyte antigen CD19, hepatocyte growth factor receptor (C-MET), Endosialin, the EGF-like domain 1 of EpCAM, encoded by exon 2, Fibroblast activation protein alpha (FAP alpha) and Insulin-like growth factor 1 receptor (IGF-IR or IGF-1 R). Further discloses bi-specific single chain antibody comprising VL and VH chains with CDRs as disclosed. Further discloses a method for producing the said antibody and pharmaceutical composition comprising the said antibody. The therapeutic application is in use of the disclosed antibody for the treatment of cancer or autoimmune diseases.
Patent NZ-591204-A (NZ)
Title: Pharmaceutical compositions and methods for stabilizing the same
Inventor: MOTHERAM RAJESHWAR
IPC: A01N43/90
Filed: 2009-07-30
Abstract: Disclosed herein is a pharmaceutical composition that is stabilised against oxidation, wherein the composition comprises: an effective amount of clevidipine or a pharmaceutically acceptable salt thereof, wherein the pH of the composition is about 6.0 to about 8.8; and an amount of H324/78 that is less than or equal to about 0.2% on a weight-to-weight basis to clevidipine, wherein oxidation of the composition is minimized during the manufacturing and storing processes, such that the amount of H324/78 is less than or equal to about 0.2% on a weight to weight basis.
Patent NZ-595814-A (NZ)
Title: Long line fishing apparatus
Inventor: MATTHEWS ADAM
IPC: A01K91/18
Filed: 2011-10-18
Abstract: 595814 Disclosed is a long line fishing apparatus that allows the fishing line to automatically be deployed into the water or to be able to be rewound back on the reel from the water without tangling through a guide. The apparatus comprises a reel able to rotate in one direction for unwinding and in an opposing direction for winding the fishing line on to the reel, and hook retaining means, the reel including a core connected between a first flange and second flange, for winding or unwinding a fishing line thereon said core between the first and second flanges. At least one of the flanges has an outer periphery edge and a centre of rotation. The fishing line includes at least one hook, and the reel is pivotally attached to the support member, and a hook retaining means is formed as at least one slot in the first flange so that the at least one hook can be retained in the at least one slot. Each slot is orientated at an angle with respect to the periphery edge wherein the angle includes an acute angle and obtuse angle, where the acute angle is provided on a leading side of each slot when unwinding and is provided on a trailing side of each slot when winding. The slots are sized to only receive the line whereby the hooks protrude on top of the first flange having the hooks held point down. The fishing line has a dropper backbone where the hooks are removably attached to trace lines and the end of the fishing line has at least one float and/or at least one anchor weight attached so that movement of the reel with respect to the end of the fishing line is caused by movement of at least one float or anchor weight moving away from the reel.
Patent NZ-601681-A (NZ)
Title: Wind resistant heater
Inventor: SMITH SCOTT
IPC: F23D14/12
Filed: 2011-02-25
Abstract: 601681 Disclosed is a radiant gas heater operable in windy conditions outside or outdoors. The heater includes one or more gas inlets (105), for receiving gas from a gas supply and one or more air inlets (110). The heater includes one or more gas burners (120A - 120E), in which gas from the one or more gas inlets (105) is burned using oxygen admitted through the one or more air inlets (110). One or more heat emitting elements (125A - 125E) are included, which emit infrared radiation using energy generated by the one or more gas burners (120A - 120E). One or more ionization probes (130A) are provided proximal to two or more of the heat emitting elements (125A - 125E) for detecting the presence or absence of a flame. A housing (115) is also provided which accommodates the one or more gas burners (120A - 120E), the one or more heat emitting elements (125A - 125E) and the one or more ionization probes (130A). One or more control units are also provided which are in electrical communication with the one or more ionization probes (130A) and the one or more gas inlets, the one or more control units operable to shut off the gas supply if the one or more ionization probes (130A) detect the absence of a flame.
Patent NZ-602610-A (NZ)
Title: A coupler
Inventor: BALEMI TIMOTHY CRAIG
IPC: E02F3/96
Filed: 2006-10-26
Abstract: 602610 This application is ultimately divided from NZ patent 550869. The claims of this application are directed to the features that provide for safety during the uncoupling of the coupler from engagement with the bucket pins. Once the first and second pins of the bucket are received within a first fixed dock (16) and a second sliding dock (behind 15) of the coupler. An actuator enables selective sliding the sliding dock relative to the fixed dock. The coupler assembly is configured such that the second pin is moved by the actuator to and between three positions: a first position at an aft end of the sliding dock’s range of travel in which a first connecting pin retaining means of the coupler is in a retracted position in which the first connecting pin retaining means (18) allows the first connecting pin to exit the first dock; a second position at a forward end of the sliding dock’s range of travel in which the first connecting pin retaining means is in an extended (down) position in which the first connecting pin retaining means prevents the first connecting pin from exiting the first dock; and a third position (illustrated) which is between the first and the second positions and in which the first connecting pin retaining means is in an extended position in which the first connecting pin retaining means prevents the first connecting pin from exiting the first dock, and in which the second connecting pin is held within the second dock by the sliding dock.
Patent NZ-603170-A (NZ)
Title: Combination of active loaded granules with additional actives
Inventor: MOHAMMAD HASSAN
IPC: C07D489/08
Filed: 2011-05-10
Abstract: Disclosed is a process for the manufacture of oral prolonged release tablets comprising an opioid antagonist such as naloxone and an opioid agonist such as hydromorphone, hydrocodone bitartrate or morphine sulphate. Particularly described is a method of manufacturing an oral prolonged release pharmaceutical tablet composition, comprising at least the steps of: a) producing granules comprising at least one prolonged release material and at least one first pharmaceutically active agent (preferably selected from oxycodone, hydromorphone, hydrocodone, tramadol or oxymorphone or their pharmaceutically acceptable salts, hydrates and solvates thereof); b) optionally selecting granules of step a) of substantially uniform size, such as wherein granules of a mean size in the range of about 100 microns to about 2.0 mm are selected in step b); c) blending said granules of step a) or step b) with at least one additional pharmaceutically active agent (preferably selected from naloxone, naltrexone or nalmephene or their pharmaceutically acceptable salts, hydrates and solvates) which is provided as such that it is not combined with an additional prolonged release material and not comprised within granules; d) compressing said blended granules of step c) to obtain an oral prolonged release pharmaceutical composition in the form of a tablet; wherein either the first pharmaceutically active agent is an opioid agonist and the additional pharmaceutically active agent is an opioid antagonist, or the first pharmaceutically active agent is an opioid antagonist and the additional pharmaceutically active agent is an opioid agonist. Also disclosed is an oral prolonged release pharmaceutical composition in tablet form obtained by the method as defined above.
Patent NZ-606281-A (NZ)
Title: 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles and uses thereof
Inventor: REDDY E PREMKUMAR
IPC: A61K31/4375
Filed: 2011-07-21
Abstract: Disclosed are 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile derivatives and analogues thereof as represented by general formula (I), wherein R1 is alkyl or cycloalkyl; and R2 is 4-(4-methylpiperazin-1-yl)anilinyl, 4-morpholinoanilinyl, 3,5-dialkoxyanilinyl or 3,4,5-trialkoxyanilinyl or a salt thereof. Also disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound as defined above, including compounds such as 8-cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile, 8-cyclohexyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile, 8-cyclopentyl-2-((3,5-dimethoxyphenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile, 8-cyclopentyl-7-oxo-2-((3,4,5-trimethoxyphenyl)amino)-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile and 8-cyclopentyl-2-((4-morpholinophenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile; for the treatment of a cellular proliferative disorder (including conditions such as cancer, hemangiomatosis in newborn, secondary progressive multiple sclerosis, atherosclerosis, chronic progressive myelodegenerative disease, neurofibromatosis, ganglioneuromatosis, keloid formation, Paget’s disease of the bone, fibrocystic disease of the breast, uterine fibroids, Peyronie’s disease, Dupuytren’s disease, restenosis, benign proliferative breast disease, benign prostatic hyperplasia, X linked lymphocellular proliferative disorder, post transplantation lymphocellular proliferative disorder, macular degeneration, retinopathies, proliferative vitreoretinopathy and non-cancerous lymphocellular proliferative disorders). Further disclosed is the use of a compound as defined above, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for inducing apoptosis of cancer cells in an individual afflicted with cancer, and particularly for tumour cells selected from the group consisting of ovarian, cervical, uterine, vaginal, breast, prostate, testicular, lung, renal, colorectal, stomach, adrenal, mouth, esophageal, hepatic, gall bladder, bone, lymphatic, eye, skin and brain tumor cells.
Patent NZ-623363-A (NZ)
Title: Mesh structure, production and uses thereof
Inventor: WALSH ANTHONY THOMAS
IPC: E02D3/00
Filed: 2012-10-23
Abstract: A one-piece plastics material mesh structure (1), particularly a geogrid for use in geoengineering construction, is produced by stretching a plastics sheet starting material (20) formed with an array of holes (21). The mesh structure (1) comprises a plurality of generally parallel rib structures (2) extending longitudinally in a first direction parallel to the stretch direction (MD) and a plurality of generally parallel bar structures (3) extending in a second direction (TD) transverse to the rib structures (2). The rib structures (2) and said bar structures (3) are interconnected by junctions (5) at spaced locations along their respective lengths whereby the rib structures (2) are sub-divided along their length into alternating junctions (5) and rib segments (6) and the bar structures are sub-divided along their lengths by alternating bar segments (7) and junctions (5). In the mesh structure (1), (a) the rib structures (2) are such that the rib segments (6) are oriented in the first direction (MD) along their lengths and orientation in the first direction (MD) extends across the junctions (5) connecting two such oriented rib segments, and (b) the bar structures (3) are such that their overall stretch ratio in the second direction (TD) is a maximum of 1 and all locations along the length of the bar structures (3) have a maximum orientation of 1.5 in the second direction (TD).
Patent NZ-707231-A (NZ)
Title: Optical tape pick up unit with holographic optical element
Inventor: WILSON SCOTT D
IPC: G11B7/1392
Filed: 2013-10-09
Abstract: An optical tape pick up system (92) for reducing wavefront error of the focused first order beams is disclosed. The optical tape pick up system (92) comprises a holographic optical element (100) and a single aspheric objective lens (102). The holographic optical element (100) is configured to split a laser beam into a zero order beam and first order beams, and to introduce wavefront error via diffraction into the first order beams but not the zero order beam. The aspheric objective lens (102) is configured to focus the beams onto optical tape and to introduce wavefront error into the first order beams. The wavefront error introduced by the element (100) offsets the wavefront error introduced by the lens (102) to reduce resulting wavefront error of the focused first order beams.
Patent NZ-707688-A (NZ)
Title: Handlebar adjusting mechanism for scooter
Inventor: TIANBO XU
IPC: B62K21/22
Filed: 2015-05-01
Abstract: The present invention relates to a handlebar adjusting mechanism for a scooter. A lower pedestal is fixedly connected to a front-wheel steering system of a scooter, while an upper pedestal is fixedly mounted with a headlight and fixed to a handlebar. A first upper pivot hole and a second upper pivot hole are provided on the upper pedestal, a first lower pivot hole and a second lower pivot hole are provided on the lower pedestal, the four pivot holes correspond to four vertexes of a parallelogram, and the plane of the parallelogram is a vertical plane parallel to a front-rear direction of the scooter. An upper end and a lower end of a first connecting rod are pivoted to the first upper pivot hole and the first lower pivot hole, respectively, an upper end and a lower end of a second connecting rod are pivoted to the second upper pivot hole and the second lower pivot hole, respectively, and the first connecting rod comprises an upper half of a first rod and a lower half of a second rod, the second connecting rod is a straight connecting rod, and an included angle is formed at a joint of the first rod and the second rod; and, a cylinder, that functions as a compact structure adjusting mechanism, is mounted in a space formed between the first connecting rod and the second connecting rod due to the included angle between the upper half and the lower half of the first connecting rod, and wherein the cylinder is configured to push the first connecting rod to move so as to adjust the height position and front-rear position of the scooter handlebar.
Patent NZ-711312-A (NZ)
Title: Substituted n-aryl pyridinones
Inventor: ZHANG CHENGZHI
IPC: A61P25/00
Filed: 2012-03-06
Abstract: The disclosure relates to the use of deuterated pirfenidone (compound (I), wherein at least one of R1 – R11 is deuterium), wherein the d-pirfenidone is administered orally between 30 minutes prior to and 2 hours after consuming food. The deuterated pirfenidone may be d3-pirfenidone and the administration with food is to reduce the incidence of gastrointestinal upset, nausea, fatigue, somnolence, dizziness, headache and photosensitivity rash and to reduce the mean maximum plasma concentration.
Patent NZ-711567-A (NZ)
Title: Antibody formulations
Inventor: PATAPOFF THOMAS
IPC: C07K16/22
Filed: 2014-03-13
Abstract: The invention provides stable aqueous pharmaceutical formulations comprising the therapeutic antibody, bevacizumab, in an amount of 45-55mg/mL, trehalose in an amount of 50-70mM, a sodium phosphate buffer in an amount of 22-28mM, polysorbate 20 in a concentration of 0.01% to 0.1% and having a pH in the range of about 5.5 to about 7.0. The invention also provides methods for making such formulations and methods of using such formulations. In the past years, advances in biotechnology have made it possible to produce a variety of proteins for pharmaceutical applications using recombinant DNA techniques.